EU
Emory University Portfolio holdings
AUM
$27.7M
This Quarter Return
+3.22%
1 Year Return
+31.53%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$117M
AUM Growth
+$117M
(-7.8%)
Cap. Flow
-$12.7M
Cap. Flow
% of AUM
-10.9%
Top 10 Holdings %
Top 10 Hldgs %
48.94%
Holding
61
New
9
Increased
18
Reduced
15
Closed
17
Top Buys
| 1 |
JD.com
JD
|
$5.15M |
| 2 |
Armstrong World Industries
AWI
|
$2.18M |
| 3 |
KKR & Co
KKR
|
$1.98M |
| 4 |
AAAP
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
|
$1.84M |
| 5 |
KALA BIO
KALA
|
$1.83M |
Top Sells
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
$3.9M |
| 2 |
RXDX
Ignyta, Inc.
RXDX
|
$2.11M |
| 3 |
WBC
WABCO HOLDINGS INC.
WBC
|
$1.74M |
| 4 |
Esperion Therapeutics
ESPR
|
$1.7M |
| 5 |
QVCGA
QVC Group, Inc. Series A Common Stock
QVCGA
|
$1.7M |
Sector Composition
| 1 | Healthcare | 44.68% |
| 2 | Financials | 35.04% |
| 3 | Consumer Discretionary | 4.42% |
| 4 | Industrials | 3.63% |
| 5 | Technology | 3.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class A
BRK.A
$1.09T
| $34.8M | 29.88% | 117 | – | – |
|
|
2
JD.com
JD
$44.1B
| $5.15M | 4.42% | +124,440 | New | +$5.15M |
|
|
TFCF
3
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $2.22M | 1.9% | 65,055 +5,804 | +10% | +$198K |
|
4
Wave Life Sciences
WVE
$1.53B
| $2.21M | 1.9% | 63,013 -33,209 | -35% | -$1.17M |
|
|
5
Armstrong World Industries
AWI
$8.47B
| $2.18M | 1.87% | +35,959 | New | +$2.18M |
|
|
GHDX
6
DELISTED
Genomic Health, Inc.
GHDX
| $2.15M | 1.85% | 62,926 +9,487 | +18% | +$324K |
|
|
ONC
7
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $2.15M | 1.84% | 21,956 -1,105 | -5% | -$108K |
|
8
Trinity Industries
TRN
$2.3B
| $2.06M | 1.77% | 54,906 -2,485 | -4% | -$93.1K |
|
9
Bread Financial
BFH
$3.09B
| $2.05M | 1.76% | 8,105 +707 | +10% | +$179K |
|
|
AVXS
10
DELISTED
AveXis, Inc. Common Stock
AVXS
| $2.05M | 1.75% | 18,474 +607 | +3% | +$67.2K |
|
11
Acadia Pharmaceuticals
ACAD
$4.38B
| $2.04M | 1.75% | 67,758 +14,781 | +28% | +$445K |
|
12
Ascendis Pharma
ASND
$11.8B
| $2.04M | 1.75% | 50,813 -9,063 | -15% | -$363K |
|
|
DBVT
13
DBV Technologies
DBVT
$264M
| $2.02M | 1.73% | 81,916 +43,535 | +113% | +$1.07M |
|
|
BHVN
14
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $2.01M | 1.72% | 74,378 +16,440 | +28% | +$444K |
|
|
ALXN
15
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $2.01M | 1.72% | 16,773 +4,490 | +37% | +$537K |
|
16
Neurogene
NGNE
$264M
| $2M | 1.72% | 170,404 +47,154 | +38% | +$555K |
|
17
Morgan Stanley
MS
$240B
| $1.99M | 1.71% | 37,911 +2,094 | +6% | +$110K |
|
|
18
KKR & Co
KKR
$124B
| $1.98M | 1.7% | +93,944 | New | +$1.98M |
|
19
BioMarin Pharmaceuticals
BMRN
$11.2B
| $1.97M | 1.69% | 22,137 +2,354 | +12% | +$210K |
|
20
Seagate
STX
$35.6B
| $1.97M | 1.69% | 47,154 -3,396 | -7% | -$142K |
|
|
ZGNX
21
DELISTED
Zogenix, Inc.
ZGNX
| $1.96M | 1.68% | 48,843 -97,414 | -67% | -$3.9M |
|
22
Amicus Therapeutics
FOLD
$2.34B
| $1.95M | 1.67% | 135,364 +2,885 | +2% | +$41.5K |
|
23
Microsoft
MSFT
$3.77T
| $1.94M | 1.66% | 22,655 -123 | -0.5% | -$10.5K |
|
24
Neurocrine Biosciences
NBIX
$13.8B
| $1.94M | 1.66% | 24,945 -5,537 | -18% | -$430K |
|
25
BioCryst Pharmaceuticals
BCRX
$1.74B
| $1.88M | 1.62% | 383,768 +23,726 | +7% | +$116K |
|